MedEdicus Podcasts

Author: MedEdicus

MedEdicus is an accredited, independent, leading developer of continuing medical education and disease awareness programs. We providee quality continuing education to health care providers and other members of the patient care team around the globe. Each of our learning opportunities offers a case-based approach to make the experience clinically relevant.MedEdicus is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians. We comply with all policies and guidelines of the US Food and Drug Administration, Office of Inspector General Guidance, and Pharmaceutical Research and Manufacturers of America Code.
Be a guest on this podcast

Language: en-us

Genres: Life Sciences, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Continuous Drug Delivery: Advancements in nAMD and DME (CME Podcast)
Wednesday, 12 March, 2025

This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical considerations for optimizing the safety and efficacy of sustained delivery, with a specific focus on the PDS surgical implantation and refill-exchange procedures. Through case-based discussions, learners will evaluate patient-specific characteristics to determine the appropriate implementation of sustained delivery platforms, considering factors such as treatment history, ocular comorbidities, and individual patient needs to select optimal treatment approaches for neovascular AMD and DME.Target Audience:Retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME.Learning Objectives:Appraise the latest data regarding the safety and efficacy of sustained delivery platforms for retinal diseases Identify technical considerations to optimize the safety and efficacy of sustained delivery therapies for retinal diseases Evaluate patient-specific characteristics when considering implementation of sustained delivery platforms for retinal diseases